FARMACIA Y TECNOLOGÍA FARMACÉUTICA
Departamento
MANUEL
GÓMEZ GUZMÁN
PROFESOR TITULAR DE UNIVERSIDAD
Publicaciones en las que colabora con MANUEL GÓMEZ GUZMÁN (23)
2023
-
Community pharmacy is the key to improving vitamin D levels
Exploratory Research in Clinical and Social Pharmacy, Vol. 9
-
Innovación docente en farmacología: relato de nuestra experiencia en el aprendizaje basado en artefactos (ABA)
Actualidad en farmacología y terapéutica, Vol. 21, Núm. 2, pp. 150-163
-
Principales barreras para la participación de pacientes y farmacéuticos en investigaciones realizadas en la farmacia comunitaria: (Proyecto INFACO: Investigación en Farmacias Comunitarias)
Ars pharmaceutica, Vol. 64, Núm. 1, pp. 12-12
2022
-
Un nuevo camino en la Atención Farmacéutica: la idoneidad de la Evaluación Clínica Objetiva Estructurada
Ars pharmaceutica, Vol. 63, Núm. 3, pp. 222-233
2021
-
Digital teams for pursuing excellence in online education
EduLearn 21 Proceedings: 13th International Conference on Education and New Learning Technologies Online Conference. 5-6 July, 2021.
-
Results of development and application of an objective structured clinical examination: A pioneering experience in pharmaceutical care
Indian Journal of Pharmaceutical Education and Research, Vol. 55, Núm. 2, pp. 621-628
2018
-
The teaching team of experienced and beginner professors contributes to the continuous improvement of the teaching in the University of Granada
Edulearn 18. 10th International Conference on Education and New Learning Technology: (Palma, 2nd-4th of July, 2018). Conference proceedings
2016
-
Vascular and central activation of peroxisome proliferator-activated receptor-β attenuates angiotensin II-induced hypertension: Role of RGS-5
Journal of Pharmacology and Experimental Therapeutics, Vol. 358, Núm. 1, pp. 151-163
2015
-
Antihypertensive effects of probiotics Lactobacillus strains in spontaneously hypertensive rats
Molecular Nutrition and Food Research, Vol. 59, Núm. 11, pp. 2326-2336
-
Chronic peroxisome proliferator-activated receptorβ/δ agonist GW0742 prevents hypertension, vascular inflammatory and oxidative status, and endothelial dysfunction in diet-induced obesity
Journal of Hypertension, Vol. 33, Núm. 9, pp. 1831-1844
2014
-
Chronic hydroxychloroquine improves endothelial dysfunction and protects kidney in a mouse model of systemic lupus erythematosus
Hypertension, Vol. 64, Núm. 2, pp. 330-337
-
PPARβ activation restores the high glucose-induced impairment of insulin signalling in endothelial cells
British Journal of Pharmacology, Vol. 171, Núm. 12, pp. 3089-3102
2013
-
Effects of peroxisome proliferator-activated receptor-β activation in endothelin-dependent hypertension
Cardiovascular Research, Vol. 99, Núm. 4, pp. 622-631
-
SIRT1 inhibits NADPH oxidase activation and protects endothelial function in the rat aorta: Implications for vascular aging
Biochemical Pharmacology, Vol. 85, Núm. 9, pp. 1288-1296
2012
-
Activation of peroxisome proliferator-activated receptor-β/-δ (PPARβ/δ) prevents endothelial dysfunction in type 1 diabetic rats
Free Radical Biology and Medicine, Vol. 53, Núm. 4, pp. 730-741
-
Different cardiovascular protective effects of quercetin administered orally or intraperitoneally in spontaneously hypertensive rats
Food and Function, Vol. 3, Núm. 6, pp. 643-650
-
Epicatechin lowers blood pressure, restores endothelial function, and decreases oxidative stress and endothelin-1 and NADPH oxidase activity in DOCA-salt hypertension
Free Radical Biology and Medicine, Vol. 52, Núm. 1, pp. 70-79
2011
-
Antihypertensive effects of peroxisome proliferator-activated receptor-β activation in spontaneously hypertensive rats
Hypertension, Vol. 58, Núm. 4, pp. 733-743
-
Antihypertensive effects of the PPAR-â agonist GW0742 in Doca-Salt hypertensive rats
Actualidad en farmacología y terapéutica, Vol. 9, Núm. 4, pp. 301-302
-
Chronic (-)-epicatechin improves vascular oxidative and inflammatory status but not hypertension in chronic nitric oxide-deficient rats
British Journal of Nutrition, Vol. 106, Núm. 9, pp. 1337-1348